Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvapufa versus separate simvastatin and omega-3 fatty acids in acute coronary syndrome
2007-005582-36Phase 2Completed
- Sponsor
- Defiante Farmacêutica
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of simvastatin and omega-3 fatty acid in acute coronary syndrome (ACS) (2 arms), sponsored by Defiante Farmacêutica. Primary endpoints: Safety and tolerability of Simvapufa, Lipid metabolism and 4 more. Started Sep 2009; status: completed.
02
Drugs
simvastatinomega-3 fatty acid
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2007-005582-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005582-36.